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Introduction {#sec1}
============

Regulation of transcription is a multistep process, initiated by the recruitment of sequence-specific transcription factors that facilitate the assembly of RNA polymerase II (RNA Pol II)-containing preinitiation complexes (PICs) at the regulatory regions of genes ([@bib17]). Although PIC recruitment controls specificity, the steps subsequent to the assembly of RNA Pol II machinery are of pivotal importance. Pausing of RNA Pol II in promoter-proximal regions and its regulated release to the productive phase of transcript elongation are part of the complex mechanisms involved in regulating the transcription of most, if not all, eukaryotic genes ([@bib31], [@bib2], [@bib23], [@bib20]). Negative elongation factor (NELF) and DRB sensitivity inducing factor (DSIF) stabilize RNA Pol II 30 to 60 nt downstream of transcription start sites (TSSs) ([@bib49], [@bib54], [@bib30]). Regulated release of RNA Pol II from the pause sites is mediated by the positive transcription elongation factor b (P-TEFb) complex, which phosphorylates the C-terminal domain of RNA Pol II at serine 2 and facilitates the eviction of NELF and DSIF ([@bib27], [@bib50]).

The role of chromatin structure in the post-recruitment processes is poorly understood. Genome-wide studies have revealed that the densities of H3K79Me~2~, H2BK120Ub~1~, and H4K20Me~1~ at gene-coding regions positively correlate with transcript elongation rates ([@bib3], [@bib15], [@bib48]). While these studies point to a regulatory function of specific histone modifications in transcript elongation, their role in the earlier post-recruitment steps, such as pausing or regulated the escape of RNA Pol II, has not yet been investigated.

Among the gene body modifications, H4K20 monomethylation is of special interest because its global levels are highly regulated during the cell cycle. H4K20Me~1~ concentrations are the highest in the G~2~/M phase, gradually decline during the G~1~ phase, and remain very low throughout the S phase ([@bib37], [@bib5], [@bib47]). This correlates with the similar cell-cycle-dependent changes in Kmt5a (also known as Setd8 or PR-Set7) protein levels, the sole enzyme catalyzing H4K20Me~1~. H4K20Me~1~ mediates chromatin condensation via the recruitment of LMBTL1, which is important for the proper transition to mitosis ([@bib22], [@bib29], [@bib44]). H4K20Me~1~ is used as substrate by Suv4-20h to generate H4K20Me~2~ and H4K20Me~3~, which enhance nucleosomal folding and heterochromatin formation ([@bib5]). Furthermore, H4K20Me~2/3~ is directly bound by ORC1 and ORCA, guiding replication origin selection ([@bib4]), or by 53BP1 at sites of DNA damage, which initiates DNA double-stranded repair ([@bib35], [@bib45]). These findings established the view that Kmt5a-mediated H4K20 methylation is required for the maintenance of genome integrity ([@bib1], [@bib35]). We previously generated adult hepatocyte-specific *Kmt5a* knockout mice (*Kmt5a*^*ΔHepA*^) that, consistent with the well-established role of Kmt5a and H4K20Me~1~ in genome integrity, displayed cell division-dependent DNA damage and hepatocyte necrosis after 3--4 months of age ([@bib33]). At earlier postnatal stages (e.g., postnatal day 45 \[P45\]), no major morphological or histological alterations could be detected. However, a small but significant increase in serum alanine aminotransferase (ALT) levels in young animals was indicative of hepatocyte dysfunction, which warranted further investigation.

Here, we investigated the early phenotypic changes in liver-specific Kmt5a-deficient mice and the in vivo function of H4K20 methylation in non-dividing hepatocytes. We show that H4K20Me~1~ turnover in gene bodies positively correlates with gene activity and RNA Pol II release from promoter-proximal regions. Most sensitive to this promoter escape regulation are genes involved in glucose and lipid homeostasis, whose defect resulted in widespread metabolic reprogramming and genome damage. The results suggest that H4K20Me~1~, in addition to its role in proper replication licensing, mitotic chromatin condensation, and DNA repair, safeguards genome integrity in non-dividing cells by controlling the transcription of metabolic genes at the post-initiation steps.

Results {#sec2}
=======

H4K20 Monomethylation Is Dynamically Deposited over the Gene Bodies of Active Genes {#sec2.1}
-----------------------------------------------------------------------------------

Mapping the genome-wide locations of H4K20Me~1~-modified nucleosomes in P45 mouse livers revealed that most (87.6%) of them are located in gene body regions between TSSs and transcription end sites (TESs) ([Figure 1](#fig1){ref-type="fig"}A). Average coverage plots of H4K20Me~1~ reads over the coding regions of annotated genes detected high methylation levels in the highly expressed genes, lower levels in the medium mRNA category genes, and low or lack of methylation in the moderately or poorly expressed gene groups ([Figure 1](#fig1){ref-type="fig"}B). Ranked coverage plot analyses of RNA Pol II chromatin immunoprecipitation sequencing (ChIP-seq) data obtained with antibody recognizing either all forms of the protein (RNA Pol II) or the form engaged in active elongation (the Ser2 form of RNA polymerase II \[RNA Pol II-Ser2\]) showed a positive, albeit not perfect, correlation with the density of H4K20Me~1~ reads ([Figures 1](#fig1){ref-type="fig"}C and 1D). Because Kmt5a is the sole enzyme that can catalyze H4K20 monomethylation, the preceding data suggest that the mechanism of methylation of transcriptionally active gene bodies may involve traveling of Kmt5a with RNA Pol II. Despite extensive efforts, we could not obtain reliable ChIP-seq data for Kmt5a distribution, probably due to the short residence time of the protein in the genome (data not shown). However, we could detect in vivo interactions between Kmt5a and all forms of RNA Pol II in co-immunoprecipitation assays ([Figure S1](#mmc1){ref-type="supplementary-material"}A).Figure 1Dynamic H4K20 Monomethylation in the Intragenic Regions of Transcriptionally Active Genes(A) Genomic distribution of ChIP-seq-enriched signal areas obtained with the H4K20Me~1~ antibody in wild-type mice. Percentages indicate the proportion of the total (12,156) enriched regions falling in the respective categories.(B) Average H4K20Me~1~ coverage profiles at the genes expressed in mouse liver. Annotated genes (18,042 genes after filtering those with \<1 kb of length) were divided into equal quartiles (high, medium, moderate, and low) according to their steady-state mRNA levels in wild-type P45 mouse livers as determined by RNA-seq analysis. The graph shows normalized average H4K20Me~1~ reads/bp at the regions extending from −1 kb of the transcription start site (TSS) to +1 kb of the transcription end site (TES).(C and D) Correlation between gene body RNA Pol II and H4K20Me~1~ coverage in the livers of P45 wild-type mice. Averaged ChIP-seq read densities of RNA Pol II (red line) and H4K20Me~1~ (green line) (C) or RNA Pol II-Ser2 (orange line) and H4K20Me~1~ (green line) (D) were ranked by increasing mRNA levels according to RPGM (reads per gene model) values. The read counts of the input sample are also shown (dark line).(E) Average H4K20Me~1~ coverage profiles of genes expressed at different levels in the livers of P45 wild-type (WT) and P45 *Kmt5a*^*ΔHepA*^ mice. High, medium, moderate, and low describe the steady-state mRNA levels of the quartiles as in (B).(F and G) Overlay of Kdm7b (blue line) with that of H3K4Me~3~ (orange line) (F) or H4K20Me~1~ (green line) (G) average ChIP-seq profiles in P45 wild-type mouse livers.(H) Correlation between Kdm7b occupancy and gene body RNA Pol II or H4K20Me~1~ read densities in the livers of P45 wild-type mice. The graphs show average coverage profiles of Kdm7b (blue line), RNA Pol II (red line), and H4K20Me~1~ (green line) in gene bodies ranked by increasing Kdm7b average read densities. The respective average gene coverage of the input sample (dark line) is also indicated.(I) Distribution of Kdm7b read densities in downstream gene body regions. The graph shows average coverage (reads/bp) of Kdm7b in regions downstream of H3K4Me~3~-containing nucleosomes in P45 wild-type livers. Group A genes (n = 95) correspond to H4K20Me~1~-containing active genes, whose overall gene body methylation levels were not significantly changed in *Kmt5a*^*ΔHepA*^ mice. Group B genes (n = 95) correspond to H4K20Me~1~-containing active genes, whose methylation levels decreased more than 3-fold in *Kmt5a*^*ΔHepA*^ mice.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

As expected, H4K20Me~1~ read densities were decreased in the livers of P45 *Kmt5a*^*ΔHepA*^ mice, which lack Kmt5a in hepatocytes from P20 ([Figure 1](#fig1){ref-type="fig"}E) ([@bib33]). However, this drop was mainly observed in the highly expressed gene group. Even in these genes, it was not eliminated, suggesting that H4K20Me~1~ is a relatively stable modification. This selective gene group-specific decrease of H4K20Me~1~ suggests that cell duplication-mediated halving cannot account for the observed H4K20Me~1~ patterns.

To test whether gene-selective enzymatic demethylation may explain the observed patterns, we mapped the binding locations of the known H4K20Me~1~ demethylase Kdm7b (also known as Phf8). Consistent with its ability to associate with H3K4Me~3~ marks ([@bib14]), Kdm7b mainly occupied promoter-proximal nucleosomes, highly overlapping with H3K4Me~3~ ChIP-seq peaks ([Figure 1](#fig1){ref-type="fig"}F). This distribution oppositely mirrored that of H4K20Me~1~, which was sharply increased in gene body nucleosomes located downstream of those modified by H3K4Me~3~ and occupied by Kdm7b ([Figure 1](#fig1){ref-type="fig"}G). The mutually exclusive occupancy pattern indicates that Kdm7b is a main H4K20 demethylase and that its activity keeps promoter-proximal nucleosomes devoid of the H4K20Me~1~ mark. Average coverage plots ranked by increasing Kdm7b read counts revealed a perfect correlation between Kdm7b and RNA Pol II occupancy ([Figure 1](#fig1){ref-type="fig"}H). This is consistent with previous studies in HeLa cells demonstrating that Kdm7b is preferentially recruited to active genes via interaction with the C-terminal domain of RNA Pol II and with nucleosomes trimethylated at H3K4 ([@bib14]). H4K20Me~1~ was enriched nearly proportionally with increasing Kdm7b occupancy, but only in genes with relatively low Kdm7b levels ([Figure 1](#fig1){ref-type="fig"}H). Genes with high levels of Kdm7b contained less H4K20Me~1~ ([Figure 1](#fig1){ref-type="fig"}H). Inspection of individual gene tracks revealed three groups of genes categorized by specific Kdm7b occupancy patterns. The first group, representing about 1.5% of active, RNA Pol II-containing genes (e.g., *Alb* and *Pck1*), had high levels of Kdm7b all over the gene bodies and not concentrated at the promoter-proximal nucleosomal regions ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These genes are highly active in wild-type livers and lack H4K20Me~1~, while RNA Pol II ChIP signals were distributed evenly along their promoter and gene bodies in both wild-type and Kmt5a-deficient livers ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The second group (∼3.6% of active genes, e.g., *Plekhm2* or *Rfc5*) is characterized by low levels or the absence of Kdm7b, high H4K20Me~1~ levels, and relatively even distribution of RNA Pol II ([Figure S1](#mmc1){ref-type="supplementary-material"}C). H4K20Me~1~ levels and RNA Pol II distribution on this group of genes were not changed significantly in Kmt5a-deficient mice. Most (92%) of the active genes belong to the third group, with high levels of Kdm7b and RNA Pol II at promoter-proximal regions and lower densities at gene bodies ([Figure S1](#mmc1){ref-type="supplementary-material"}D). In most of these genes, H4K20 methylation is reduced in *Kmt5a*^*ΔHepA*^ proportional to the amounts of Kdm7b in the gene bodies. Genes with a high degree of H4K20Me~1~ loss in *Kmt5a*^*ΔHepA*^ mice had low but detectable amounts of Kdm7b in gene bodies downstream of the promoter-proximal nucleosomes, while those whose H4K20Me~1~ levels was unchanged had near-baseline Kdm7b levels ([Figure 1](#fig1){ref-type="fig"}I; [Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B).

These results suggest that the antagonistic action of Kmt5a methylase and Kdm7b demethylase generates a dynamic H4K20 monomethylation pattern across the gene bodies of transcriptionally active genes, which correlates with specific distribution patterns of RNA Pol II.

Kmt5a Regulates RNA Pol II Escape from the Promoter-Proximal Regions {#sec2.2}
--------------------------------------------------------------------

Analysis of global RNA Pol II distribution profiles revealed that gene body H4K20Me~1~ positively correlated with the amounts of the elongating, Ser2-phosphorylated form of RNA polymerase II (RNA Pol II-Ser2P) ([Figure 2](#fig2){ref-type="fig"}A). H4K20Me~1~ levels also correlated with nascent RNA reads determined by sequencing of newly synthesized RNA labeled in vivo by ethynyl-uridine ([Figure 2](#fig2){ref-type="fig"}A, right). In *Kmt5a*^*ΔHepA*^ mice, the amounts of RNA Pol II-Ser2P decreased only in the group of genes (group B) in which significant loss of H4K20Me~1~ was detected, not in the group (group A) in which H4K20Me~1~ remained unaffected by *Kmt5a* inactivation ([Figure 2](#fig2){ref-type="fig"}B; [Figure S2](#mmc1){ref-type="supplementary-material"}A). Similar differences in gene body locations were observed in ChIP-seq assays performed with an antibody recognizing all forms of RNA Pol II ([Figure 2](#fig2){ref-type="fig"}C). In this latter assay, we noticed that promoter and promoter-proximal region-bound RNA Pol II was only marginally reduced in group B genes, while gene body-bound RNA Pol II reads decreased at a larger extent. To obtain a quantitative view, we calculated the normalized RNA Pol II coverage (reads per base pair \[bp\]) in the 500 bp area centered on the TSSs and divided by the same window length of normalized RNA Pol II coverage in the rest of the gene body (promoter + pausing index \[PrI\]). Increased PrI values in *Kmt5a*^*ΔHepA*^ mice were observed only in genes (group B) whose gene body methylation was highly reduced in the absence of Kmt5a ([Figure 2](#fig2){ref-type="fig"}D). As an independent analysis, we grouped active genes according to their PrIs and compared the H4K20Me~1~ coverage in their gene bodies. The average H4K20Me~1~ levels were higher in genes with higher PrI values as opposed to those with PrI values near 1 ([Figure S2](#mmc1){ref-type="supplementary-material"}C). These results demonstrate that Kmt5a function is important for the regulation of RNA Pol II escape from the promoter or promoter-proximal regions.Figure 2H4K20 Monomethylation Correlates with RNA Pol II Distribution on Active Genes(A) Average H4K20Me~1~ (left panel), RNA Pol II-Ser2 (middle panel), and in vivo ethynyl-uridine (EU)-labeled nascent RNA (right panel) coverage profiles at the genes expressed in P45 wild-type mouse livers. Genes containing H4K20Me~1~ in their gene bodies (n = 6,570 genes with normalized reads per gene length \> 0.03 bp) were divided into quartiles (high, red line, n = 1,643; medium, green line, n = 1,642; moderate, blue line, n = 1,642; and low, orange line, n = 1,643) according to H4K20Me~1~ read densities. The distribution over non-methylated, annotated genes (n = 11,472 genes) is shown by the gray line. The graphs show average coverage of ChIP-seq reads obtained with H4K20Me~1~ and RNA Pol II-Ser2 antibodies and EU-labeled nascent RNA reads over the gene body regions.(B and C) Distribution of RNA Pol II-Ser2 (B) and total RNA Pol II (C) in the group of genes displaying low (group A) and high (group B) H4K20Me~1~ methylation turnover. The graphs show average coverage of ChIP-seq reads.(D) Quantitative comparison of changes in PrIs in hepatic genes displaying different methylation turnover. The PrI was calculated as the ratio of the normalized RNA Pol II coverage (reads/bp) of a 500 bp area around the TSS of mouse genes divided by the window length (500 bp) to the normalized RNA Pol II coverage over the rest of the gene body. Boxplots depict changes in PrI values between wild-type and *Kmt5a*^*ΔHepA*^ mice (knockout \[KO\]) in group A and group B genes as indicated. Statistical significance was assessed by Welch's t test.(E) Distribution of nascent RNA reads labeled by Bromo-Uridine (BrU) in isolated nuclei evaluated by GRO-seq (GRO-RNA) in group A and group B genes. Note the different scales of the y axis.(F) Pausing index (PI) calculated as the ratio of the normalized nascent RNA coverage (reads/bp) in the TSS to the +50 nt area of mouse genes divided by the window length (500 bp) to the normalized nascent RNA coverage over the rest of the gene body. The results are presented in boxplots as in (D).(G) Distribution of in vivo nascent RNA reads by EU (nascent RNA in vivo) in group A and group B genes. Note the different scales of the y axis.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

The preceding results were confirmed by the higher-resolution approach of global run-on sequencing (GRO-seq). In these assays, isolated nuclei are incubated with Bromo-Uridine triphosphate (Br-UTP) for a short time in the presence of sarcosyl, which limits the extension of nascent RNAs to already engaged polymerases ([@bib9]). In agreement with the RNA Pol II distribution profile, we observed high-level accumulation of short 30--50 nt transcripts that map downstream of the TSS ([Figure 2](#fig2){ref-type="fig"}E). As in other systems, we could also detect significant levels of promoter transcription in both group A and group B genes ([Figure 2](#fig2){ref-type="fig"}E). The resolution of this analysis also allowed the calculation of pausing indexes (PIs). Similar to the PrI ratios calculated from RNA Pol II distribution data, we observed increased pausing index values in *Kmt5a*^*ΔHepA*^ mice only in group B genes ([Figure 2](#fig2){ref-type="fig"}F).

The role of H4K20 methylation in nascent RNA synthesis was further demonstrated by the in vivo nascent RNA sequencing (RNA-seq) approach, in which newly synthesized RNA is labeled by ethynyl-uridine treatment of live animals. Although this assay does not detect promoter-proximal short transcripts, it provides valuable information about the in vivo dynamics of new RNA synthesis. Kmt5a inactivation resulted in reduced synthesis of new transcripts only in the group B gene category ([Figure 2](#fig2){ref-type="fig"}G).

These results suggest that Kmt5a regulates transcription at the step involving the escape of RNA Pol II from promoter-proximal locations.

Kmt5a-Mediated H4K20 Methylation Regulates Genes Involved in Glucose and Lipid Homeostasis {#sec2.3}
------------------------------------------------------------------------------------------

Gene expression profiling by RNA-seq identified 1,030 downregulated and 760 upregulated genes in the livers of P45 *Kmt5a*^*ΔHepA*^ mice compared to wild-type littermates ([Figure 3](#fig3){ref-type="fig"}A). Among the downregulated genes, only 217 had decreased levels of H4K20 monomethylation ([Figure 3](#fig3){ref-type="fig"}B). These 217 genes represent only a fraction of the 1,896 genes whose H4K20Me~1~ levels decreased in P45 *Kmt5a*^*ΔHepA*^ mice ([Figure 3](#fig3){ref-type="fig"}B).Figure 3The Steady-State mRNA Levels of Only a Limited Number of Genes Are Affected by H4K20 Monomethylation(A) Mean-difference plot depicting the gene expression changes in the livers of *Kmt5a*^*ΔHepA*^ against wild-type mice. Red dots and green dots correspond to upregulated and downregulated genes with a p value \< 0.05, respectively. Gray dots correspond to all other genes.(B) Venn diagram showing the overlap between genes whose mRNA and H4K20Me~1~ levels decreased in *Kmt5a*^*ΔHepA*^ mice.(C) Scatterplots showing the relationship between promoter (y axis) and gene body (x axis) occupancy of RNA Pol II in the 217 genes identified in (B) as correlating with changes in H4K20Me~1~ levels. Genes are categorized, according to their read enrichment in promoters versus gene bodies, into four groups, as indicated at the right. Color codes and the respective numbers indicate the transition of genes among the different categories. For example, 60 of the 125 genes of the high promoter/high gene body category moved to the high promoter/low gene body group in *Kmt5a*^*ΔHepA*^ mice.(D) Gene set enrichment analysis (GSEA) for the CHREBP-regulated (MLXIPL) (left panel) and the SREBF1-regulated (right panel) pathways. The figures depict the enrichment score (ES) as derived by gene set enrichment analysis for the two gene sets.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

The RNA Pol II distribution profile of the 217 genes displayed a clear shift of RNA Pol II from gene bodies to promoter-proximal regions ([Figure 3](#fig3){ref-type="fig"}C), which is in agreement with a role of H4K20Me~1~ in RNA Pol II escape from the promoter-proximal regions.

H4K20Me~1~-sensitive genes were highly enriched in metabolism-related biological process terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway categories ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Among them were *Mlxipl* (also called *Chrebp*) and *Srebf1*, two main regulators of glucose and fatty acid synthesis pathways ([@bib13], [@bib18], [@bib19], [@bib46]). The RNA Pol II distribution, Kdm7b binding, H4K20Me~1~, nascent RNA synthesis, and GRO-seq profiles of these regulators demonstrate that their expression is directly regulated by Kmt5a-dependent transition of RNA Pol II from the pause sites ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Gene set enrichment analysis revealed that most Mlxipl and Srebf1 targets were greatly affected by *Kmt5a* inactivation ([Figure 3](#fig3){ref-type="fig"}D). The mRNA and protein levels of both *Mlxipl* and *Srebf1*, as well as the mRNAs of key glycolytic, lipogenic, and cholesterol biosynthetic enzymes such as *Pklr*, *Gck*, *Fasn*, *Acc1*, *Scd1*, and *Hmgcr*, were significantly decreased in the livers of P45 *Kmt5a*^*ΔHepA*^ mice ([Figures 4](#fig4){ref-type="fig"}A--4E). We also detected increased mRNA levels of the genes involved in fatty acid uptake, hydrolysis, and detoxification (*Cd36*, *Acot1*, *Cyp2a4*, *Cyp2a14*, and *Cyp2a10*) and of the genes of the fatty acid β-oxidation and ketogenesis pathways (*Cpt1a*, *Hmgcs2*, and *Fgf21*) ([Figures 4](#fig4){ref-type="fig"}F and 4G). These latter genes are known targets of peroxysome proliferator-activated receptor alpha (Pparα), a nuclear receptor, which is activated by endogenous fatty acid ligands ([@bib11], [@bib28], [@bib24]). Comparisons with Pparα ChIP-seq data from [@bib24] revealed that a large part (43%) of the upregulated genes are bona fide functional targets of Pparα ([Figure 4](#fig4){ref-type="fig"}H).Figure 4Kmt5a Regulates Genes Involved in Glucose and Lipid Homeostasis(A) mRNA levels of *Srebf1* and *Mlxipl* in the livers of P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. Bars represent mean mRNA levels normalized to Gapdh mRNA and ±SEM from n = 5 individual mice. The data are expressed relative to the values obtained with wild-type mice. ^∗∗∗^p \< 0.0001.(B) Western blot analyses of liver extracts were performed with antibodies against Mlxipl (left panel) or Srebf1 (right panel) or control antibodies recognizing TFIIB (bottom panels). NS, non-specific band.(C--G) mRNA levels of the genes encoding the rate-limiting enzymes of glycolysis (C), de novo lipogenesis (D), cholesterol synthesis (E), Fatty acid metabolism and detoxification (F) and fatty acid oxidation (G) pathways in the livers of P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. The genes and the pathways involved are indicated above the graphs. Bars represent mean mRNA levels normalized to Gapdh mRNA and ±SEM from n = 5 individual mice. The data are expressed relative to the values obtained with wild-type mice. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(H) Venn diagram showing the overlap between genes upregulated in *Kmt5a*^*ΔHepA*^ mice and those bound by liganded Pparα. Pparα occupancy data were retrieved from [@bib24] (GEO: [GSE44571](ncbi-geo:GSE44571){#intref0020}).See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

The preceding changes resulted in impaired glucose tolerance of *Kmt5a*^*ΔHepA*^ mice ([Figure 5](#fig5){ref-type="fig"}A), without significant loss in insulin sensitivity ([Figures 5](#fig5){ref-type="fig"}B and 5C). Periodic acid Schiff (PAS) staining revealed an excessive accumulation of intracellular glycogen, as expected from the inhibition of the glycolysis pathway ([Figure 5](#fig5){ref-type="fig"}D). The shape of the glucose tolerance curve showed higher differences in early time points and full remission 2 hr following glucose challenge ([Figure 5](#fig5){ref-type="fig"}A), which points to a mechanism involving delayed glucose uptake due to high cellular glycogen content. Consistent with the changes in the mRNA levels of lipid metabolic enzymes, serum cholesterol and triglyceride levels decreased, while free fatty acids and β-hydroxybutyrate levels were increased in *Kmt5a*^*ΔHepA*^ mice ([Figure 5](#fig5){ref-type="fig"}E).Figure 5Metabolic Phenotypes in *Kmt5a*^*ΔHepA*^ Mice(A and B) Glucose tolerance and insulin sensitivity tests in P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. Plasma glucose levels were measured at the indicated time points after the administration of 1 g/kg glucose (A) or 0.5 units/kg insulin (B) in n = 5 individual mice. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(C) Average serum glucose levels in 5 hr fasted P45 mice. n = 5.(D) Representative images of liver sections stained with periodic acid Schiff (PAS) staining of glycogen. The bar graph at the right shows colorimetric measurement of glycogen in liver extracts from P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. n = 5. ^∗∗∗^p \< 0.001.(E) Serum total cholesterol, triglyceride, free fatty acid, and β-hydroxybutyrate levels in P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. n = 5. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.

These data suggest that Kmt5a-dependent regulation of RNA Pol II escape from promoter-proximal regions affects the steady-state mRNA levels of only a subset of genes. They encode for key regulators and enzymes of glycolysis, de novo lipogenesis, and cholesterol biosynthesis pathways. These are accompanied by significant changes in the levels of serum and in the cellular levels of metabolic intermediates, which trigger additional indirect effects via the activation of Pparα and its target genes.

Kmt5-Dependent Regulation of Metabolic Gene Transcription Is Important for the Maintenance of Genome Integrity {#sec2.4}
--------------------------------------------------------------------------------------------------------------

The metabolic changes observed in the livers of *Kmt5a*^*ΔHepA*^ mice resemble to a condition of energy starvation, which primarily originates from the defects in the glycolysis pathway. In line with this, AMP-ADP/ATP ratios in the livers of *Kmt5a*^*ΔHepA*^ mice were increased significantly ([Figure 6](#fig6){ref-type="fig"}A). The overall ATP levels were about 38% higher in *Kmt5a*^*ΔHepA*^ mice compared to wild-type littermates, which is likely a result of an increased mitochondrial activity (described later). The increased ADP/ATP ratio arises from a more pronounced (about 125%) increase of ADP levels, which is expected to activate AMP-activated protein kinase (AMPK), the major regulator of cellular energy homeostasis ([@bib7], [@bib16], [@bib6]). We detected constitutively active AMPK in the livers of *Kmt5a*^*ΔHepA*^ mice using an antibody specifically recognizing the Thr172-phosphorylated form of the enzyme ([Figure 6](#fig6){ref-type="fig"}B). As a consequence of persistent AMPK activation, we detected highly increased mitochondrial activity by staining with the mitochondrial marker carbamoyl phosphate synthetase 1 (CPS1) and by measuring the enzymatic activity of the cytochrome *c* oxidase (COX) complex ([Figure 6](#fig6){ref-type="fig"}C). Electron microscopy imaging revealed that in *Kmt5a*^*ΔHepA*^ mice, increased mitochondrial activity correlated with an enlargement of most mitochondria ([Figure 6](#fig6){ref-type="fig"}D). In addition, consistent with the autophagy-stimulating function of AMPK, we frequently (in five of seven hepatocytes) observed autophagic vesicles by electron microscopy and detected increased levels of the lipidated form of Map1lc3a (LC3-II) in liver extracts from *Kmt5a*^*ΔHepA*^ mice ([Figures 6](#fig6){ref-type="fig"}D and 6E).Figure 6Constitutive AMPK Activation and Increased Mitochondrial Activity in the Livers of *Kmt5a*^*ΔHepA*^ Mice(A) ATP and ADP levels in liver extracts from P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. n = 5. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(B) Western blot analysis of liver extracts with antibodies recognizing a Thr172-phosphorylated form of AMPK (top panel) or total AMPK protein (bottom panel).(C) Representative immunohistological staining of liver sections with anti-carbamoyl phosphate synthetase (CPS) antibody recognizing the mitochondrial CPS1 enzyme. Panels at the right show cytochrome oxidase I (COI) and cytochrome oxidase IV (COIV) enzymatic activities in liver extracts from P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. n = 5. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(D) Electron microscopic images of liver sections from P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. Blue arrows indicate normal-sized mitochondria. Red arrows indicate enlarged mitochondria. Green arrows depict autophagosome structures. Note the larger magnification in the bottom-right panel.(E) Western blot analysis of liver extracts with an antibody recognizing the autophagy marker protein LC3 (top panel) and Gapdh (bottom panel).See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

To test whether the gluconeogenesis pathway is affected by *Kmt5a* inactivation, we performed pyruvate tolerance tests. Surprisingly, exogenously added sodium pyruvate was not converted to glucose but instead generated a metabolic imbalance of irreversible hypoglycemia ([Figure 7](#fig7){ref-type="fig"}A). In parallel, hepatocytes became abnormally enlarged, resembling to damaged, senescent cells surrounded by invading inflammatory cells ([Figure 7](#fig7){ref-type="fig"}B). Similar abnormal enlargement of hepatocytes was observed when *Kmt5a*^*ΔHepA*^ mice were exposed to other metabolic stress conditions, such as high-fat diet or fasting for 24 or 48 hr ([Figure S5](#mmc1){ref-type="supplementary-material"}A). As expected from the increased mitochondrial activity, we detected increased amounts of reactive oxygen species (ROS) in the livers of *Kmt5a*^*ΔHepA*^ mice ([Figures 7](#fig7){ref-type="fig"}C and 7D). These levels probably are not sufficient to induce spontaneous DNA damage, because they were not accompanied by increases in γH2AX-positive cells, at least during the time frame of our analyses ([Figure 7](#fig7){ref-type="fig"}E). However, ROS levels were highly increased in response to fasting or sodium pyruvate treatment, resulting in the appearance of a high number of γH2AX-positive hepatocytes ([Figures 7](#fig7){ref-type="fig"}C--7E) and an excessive accumulation of the senescence marker SA-β-gal ([Figure S5](#mmc1){ref-type="supplementary-material"}B). The preceding phenotypic changes point to excessive liver damage, which was confirmed by highly increased serum ALT levels ([Figure 7](#fig7){ref-type="fig"}F).Figure 7Metabolic Stress Induces Rapid Accumulation of ROS and DNA Damage in the Livers of *Kmt5a*^*ΔHepA*^ Mice(A) Pyruvate tolerance tests in P45 wild-type and *Kmt5a*^*ΔHepA*^ mice. Plasma glucose levels were measured at the indicated time points after the administration of 2 g/kg Na-pyruvate in n = 5 individual mice. ^∗∗∗^p \< 0.001.(B) H&E staining of liver sections from P45 wild-type and *Kmt5a*^*ΔHepA*^ mice that were treated with 2 g/kg Na-pyruvate for 2 hr.(C) Analysis of ROS accumulation. Liver sections from mice fed a normal chow diet, fasted for 48 hr, or treated with 2 g/kg Na-pyruvate for 2 hr were stained with 5-(and-6)-chloromethyl-2\',7\'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H~2~DCFDA), as indicated.(D) Quantitative comparison of CM-H~2~DCFDA-positive areas in liver sections of (C). Positively stained areas in 20 high-power fields were measured by ImageJ software in liver sections of P45 wild-type or *Kmt5a*^*ΔHepA*^ mice. Bars graphs show fold changes of the average positively stained areas from n = 5 mice. ^∗∗^p \< 0.01.(E) Analysis of DNA damage. Liver sections from mice treated as in (C) were stained with antibody against γH2AX.(F) Serum ALT levels were measured in mice treated as in (C). Bars represent mean values of ALT levels and SEM from liver extracts of five individual mice. ^∗∗∗^p \< 0.001.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

Collectively, the preceding results suggest that in P45 *Kmt5a*^*ΔHepA*^ hepatocytes, AMPK-dependent pathways are activated to compensate for defects in glycolysis, which results in a labile state highly sensitive to stress conditions. Upon metabolic stress, rapid and irreversible accumulation of DNA damages occurs, leading to excessive cellular senescence and liver function failure.

Discussion {#sec3}
==========

The results of this paper demonstrate that Kmt5a controls the initial phase of transcription elongation and that the genes of glucose and lipid homeostasis pathways are particularly sensitive to alterations of this regulatory process. This regulatory function at the post-initiation phase of transcription is required for the maintenance of genome stability in non-dividing cells.

A possible role of H4K20Me~1~ in transcription regulation has been raised by several previous reports, albeit with contradictory conclusions. H4K20 methylation has been linked to transcription activation of estrogen-responsive ([@bib25]), Wnt-inducible ([@bib26]), neuronal ([@bib52]), and PPARγ-activated promoters ([@bib51]). Other studies demonstrated that H4K20Me~1~ modification is restricted to gene body regions of active genes in CD4^+^ T cells ([@bib3]) and in nine Encyclopedia of DNA Elements (ENCODE) cell lines ([@bib5]) and that gene body H4K20 methylation positively correlates with elongation rates in K562 cells ([@bib48]). In contrast, other global studies or mRNA analyses of specific genes suggested that H4K20Me~1~ represses transcription ([@bib8], [@bib1], [@bib21], [@bib42]). Concern about a functional role in transcription also arises from the H4K20Me~1~ levels in cultured cells being highest in the G~2~/M phase, when transcription is generally shut down, but highly reduced during the G~1~ phase and eliminated in the S phase, when genes are actively transcribed ([@bib37], [@bib1], [@bib35]).

To investigate the role of H4K20Me~1~ in the in vivo organismal context and to eliminate potential cell-cycle-dependent effects, the present study was conducted in mouse livers, populated mainly by non-dividing G~0~-phase hepatocytes. In agreement with a potential transcription activation function, we detected high levels of H4K20Me~1~ in the gene body regions of actively transcribed genes and a strong positive correlation with gene activity. Kmt5a interaction with RNA Pol II in vivo provides a plausible mechanism for Kmt5a recruitment and enzymatic modification of nucleosomes in the actively transcribed genomic regions. H4K20Me~1~ levels at the different gene body locations are determined by the frequency with which the RNA Pol II/Kmt5a complex encounters the underlying nucleosomes and the localized activity of Kdm7b demethylase.

RNA Pol II distribution in most hepatic genes is bimodal, with a large fraction of RNA Pol II concentrated near the TSS. This distribution is characteristic to genes in which RNA Pol II is paused at promoter-proximal regions ([@bib2]). Reduction of gene body H4K20 monomethylation in *Kmt5a*^*ΔHepA*^ mice correlated with decreased levels of elongating RNA Pol II and elevated ratios of promoter/promoter-proximal and gene body RNA Pol II reads (PrI). These data suggest that Kmt5a-mediated H4K20Me~1~ is involved in the regulation of transition of RNA Pol II from the initiation or the paused state to the active elongation phase. The accumulation of short reads in our GRO-seq experiments indicates that Kmt5a regulates mainly the step of RNA Pol II escape from promoter-proximal pause sites.

Although Kmt5a does not methylate histone residues other than H4K20 ([@bib5]), similar to other histone-modifying enzymes, it can methylate non-histone substrates such as p53 and proliferating cell nuclear antigen (PCNA) ([@bib39], [@bib41]). This raises the possibility that Kmt5a-mediated regulation of transcription elongation may be driven not solely through H4K20 methylation but also through the modification of another, so far unidentified target or targets. Given the strong correlations among H4K20Me~1~, Kdm7b, and RNA Pol II distribution in different genes, we think that this scenario is unlikely, although it cannot be excluded.

The sharp increase of H4K20Me~1~ in regions downstream of the promoter-proximal nucleosomes and the opposite distribution of RNA Pol II in most active genes raises the possibility that this modification may act as an obstacle for the movement of RNA Pol II and thus contribute to its retention at pause sites. Consistent with this, full erasure of H4K20Me~1~ by high levels of Kdm7b in a specific set of genes (e.g., *Alb*) correlated with highly increased transcription and lack of promoter-proximal pausing. However, this simplistic scenario is challenged by the observation of decreased levels of elongating polymerase in genes in which H4K20Me~1~ was reduced following *Kmt5a* inactivation. Taking the preceding into consideration, we propose that the actual rate of H4K20Me~1~ turnover, rather than the absolute H4K20Me~1~ levels, is important for the regulation of RNA Pol II escape from promoter-proximal regions. In other words, rather than acting as a static chromatin modification, H4K20Me~1~ functions as a transient operational mark whose deposition-removal rate can support RNA Pol II transit into gene bodies. This notion is reinforced by the results showing that gene body H4K20 monomethylation is a highly dynamic process and that increased promoter-proximal/gene body ratios of RNA Pol II (PrI) in *Kmt5a*^*ΔHepA*^ mice are preferentially detected in genes that are modified in a highly dynamic manner.

Escape of RNA Pol II from promoters and/or promoter-proximal pause sites is a general regulatory step of the transcription mechanism ([@bib2]). Interference with this process is expected to influence the expression of most regulated genes and thus affect a variety of biological functions in any given cell type. Consistent with this notion, genetic or pharmacological inactivation of pTEF-b kinase complex subunits, which play a key role in RNA Pol II release from pause sites, leads to early embryonic lethality in a variety of organisms, including mice, *C. elegans*, and *Drosophila* ([@bib40], [@bib10], [@bib36]).

The results presented here demonstrate that reduced Kmt5a-mediated partial RNA Pol II blockage influences the steady-state mRNA levels of only a fraction of genes. This indicates that compensatory mechanisms, such as mRNA stabilization, are activated to maintain the expression of most hepatic genes. Genes encoding the rate-limiting enzymes of glycolysis and de novo lipogenesis are particularly sensitive to defects of RNA Pol II escape from promoter-proximal sites. Their expression significantly drops in the livers of *Kmt5a*^*ΔHepA*^ mice by mechanisms involving reduced gene body H4K20 methylation and the decreased protein levels of the major transactivators Mlxipl and Srebf1. Transcription of *Mlxipl* and *Srebf1* is also a subject of H4K20 methylation-dependent regulation. Thus, metabolic genes are highly regulated at both transcription factor-mediated PIC formation step (Mlxipl and Srebf1 recruitment) and post-recruitment steps involving Kmt5a-dependent RNA Pol II escape. The biological significance of this dual control could be the provision of additional regulatory checkpoints to specific metabolic genes for fast and efficient adjustments of their expression under various conditions.

The defects in metabolic gene transcription in *Kmt5a*^*ΔHepA*^ mice result in extensive metabolic reprogramming, which is schematically presented in [Figure S6](#mmc1){ref-type="supplementary-material"}. Impaired glycolytic activity leads to accumulation of glycogen and elevated levels of AMP and ADP, which in turn activate of AMPK. Constitutively active AMPK in *Kmt5a*^*ΔHepA*^ hepatocytes increases fatty acid uptake by inducing the expression of CD36 transporter and autophagy. Fatty acids are ligands of PPARα, which stimulates their catabolism via the mitochondrial β-oxidation and ketogenesis pathways, both of which can serve as efficient alternative energy sources. The preceding AMPK-mediated pathways partially compensate for the loss of glucose-dependent energy supply. At the same time, the cells enter a less stable physiological state, which is highly sensitized to metabolic stress conditions. Upon metabolic stress, such as fasting, high-fat diet, or Na-pyruvate challenge, metabolic imbalances cannot be compensated, resulting in excessive increase of intracellular ROS levels and extensive DNA damage. The accumulation of DNA damages quickly aggravates into a senescent phenotype and liver dysfunction.

Altogether, the results of this study highlight a previously unanticipated dimension of Kmt5a function as gatekeeper of genome integrity: They identify a role in the regulation of transcription, through which it controls metabolic homeostasis and protects cells from metabolic stress-mediated DNA damage and cellular senescence.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

Kmt5a^ΔHepA^ mice have been described previously ([@bib33]). These animals were generated by crossing KMT5A^loxp^ mice carrying the floxed exon 7 allele of KMT5A ([@bib34]) with Alb-Cre mice ([@bib53]) in a C57BL/6 background. Mice were maintained in grouped cages in a temperature-controlled, pathogen-free facility on a 12 hr light/dark cycle and fed a standard chow diet (19% protein, 5% fat; Altromin 1324) or high-fat diet (34% crude fat, 23% crude protein, 5% crude fiber; Mucedola) and water ad libitum. All animal experiments were approved by the Prefecture of Attica and were performed in accordance with the respective national and European Union regulations. All experiments were performed in randomly chosen age-matched male mice. Typically, each experiment was performed in tissues from at least five individual mice. No blinding was used in this study.

RNA Purification and RT-PCR {#sec4.2}
---------------------------

Total RNA was prepared by TRIzol extraction as described in [@bib38] and [@bib12]. For first-strand cDNA synthesis, 1 μg of total RNA was incubated with 200 units of Moloney Murine Leukemia Virus (MMLV) reverse transcriptase in a buffer containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl~2~, and 10 mM DTT for 60 min at 37°C. qPCR analyses were carried out in a StepOne real-time PCR detection system using Fast Start Universal SYBR Green Master. Primer sequences are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

Histology, Metabolite and Enzyme Measurements, and ChIP-Seq and RNA-Seq Assays {#sec4.3}
------------------------------------------------------------------------------

Histological examination, metabolic parameter determination, ChIP assays, and steady-state RNA measurements were performed as described in [@bib43] and [@bib32]. Details and modifications of these techniques, including nascent RNA measurements and data analyses, are described in the [Supplemental Information](#app2){ref-type="fn"}.

Statistical Analysis {#sec4.4}
--------------------

Statistical significance of the data obtained from different biological replicates was evaluated by two-tailed Student's t test. In the evaluation of pausing indexes or PrIs, Welch's t test was used.
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